The market shrugged at Mesoblast’s latest FDA win. Is it just another Droneshield?
Mesoblast (ASX:MSB) has revealed the US FDA has given its flagship drug…
Mesoblast Limited (ASX:MSB)
About Mesoblast Limited
Key Information
MSB In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 08.21am 06/06/2025 | Becoming a substantial holder | 443.55KB | 6.2K |
| 05/06/2025 | Becoming a substantial holder | 2.02MB | 6.9K |
| 03/06/2025 | Becoming a substantial holder | 1006.62KB | 1.6K |
| 03/06/2025 | Ceasing to be a substantial holder | 1.37MB | 9.5K |
| 15/05/2025 | Price Sensitive PS FDA Provides Ryoncil 7 Years Orphan-Drug Exclusive Approval | 173.92KB | 102K |
| 14/05/2025 | Becoming a substantial holder | 1.85MB | 9.4K |
| 09/05/2025 | Ceasing to be a substantial holder | 1.27MB | 8.3K |
| 08/05/2025 | Becoming a substantial holder | 1.97MB | 3.1K |